AVIDATRO Trademark

Trademark Overview


On Wednesday, November 13, 2019, a trademark application was filed for AVIDATRO with the United States Patent and Trademark Office. The USPTO has given the AVIDATRO trademark a serial number of 88690331. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Amgen Inc.. The AVIDATRO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
avidatro

General Information


Serial Number88690331
Word MarkAVIDATRO
Filing DateWednesday, November 13, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements


Goods and Servicespharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amylodiosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021EXTENSION 2 GRANTED
Tuesday, July 27, 2021EXTENSION 2 FILED
Tuesday, July 27, 2021TEAS EXTENSION RECEIVED
Thursday, February 4, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 2, 2021EXTENSION 1 GRANTED
Tuesday, February 2, 2021EXTENSION 1 FILED
Tuesday, February 2, 2021TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 12, 2020ASSIGNED TO LIE
Friday, May 8, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 8, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 27, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 27, 2019NON-FINAL ACTION E-MAILED
Friday, December 27, 2019NON-FINAL ACTION WRITTEN
Thursday, December 26, 2019ASSIGNED TO EXAMINER
Tuesday, November 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 16, 2019NEW APPLICATION ENTERED IN TRAM